OligoTune
1 known investors
Oligotune is developing RNA-based cancer immunotherapy treatments that target solid tumours with enhanced precision. The company uses a data-driven pre-clinical R&D pipeline to address mechanisms in cancer immunotherapy that existing treatments do not adequately target.
Founders & leadership
Investors · 1
Frequently asked questions
- What does OligoTune do?
- Oligotune is developing RNA-based cancer immunotherapy treatments that target solid tumours with enhanced precision. The company uses a data-driven pre-clinical R&D pipeline to address mechanisms in cancer immunotherapy that existing treatments do not adequately target.
- Who founded OligoTune?
- OligoTune was founded by Loïc, Robert.
- Who are OligoTune's investors?
- OligoTune's investors include Deep Science Ventures.